RHEA FRANS: Open Payments
NPI 1114540184 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 25 payments from 8 companies in 2025. Trend: 2023 $85 · 2024 $319 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $146 |
| SHIELD THERAPEUTICS INC | 6 | $143 |
| Exeltis, USA Inc. | 3 | $61 |
| Organon LLC | 2 | $28 |
| Innovation Technologies Inc | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $24 |
| ConvaTec Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Veozah, ACCRUFER, SLYND, NEXPLANON, IRRISEPT, THINPREP 2000 PROCESSOR, AQUACEL AG+ EXTRA, Lynkuet.
Industry payments across OK — which companies pay providers there.
